Inclusion Body Myositis clinical trials at UC Health
1 research study open to new patients
open to eligible people ages 45 years and up
Funding Source - FDA OOPD. The purpose of this study is to evaluate the safety and efficacy of the study drug, Arimoclomol in IBM patients.
at UC Irvine